Illumina is investing in a £ 30 million risk fund to improve progress in human health
SAN DIEGO, April 1 / PRNewswire / – LifeArc, Illumina and Illumina Ventures investments fund genomic startups for Illumina Accelerator Cambridge graduates Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array technologies, today announced its investment in Time Boost Capital I LP, a £ 30 million venture fund for genomics, a startup …
Illumina is investing in a £ 30 million risk fund to improve progress in human health Read More »